Bridget T. Hill

6.5k total citations
193 papers, 5.3k citations indexed

About

Bridget T. Hill is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Bridget T. Hill has authored 193 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Molecular Biology, 90 papers in Oncology and 18 papers in Organic Chemistry. Recurrent topics in Bridget T. Hill's work include Cancer therapeutics and mechanisms (63 papers), Cancer Treatment and Pharmacology (32 papers) and DNA Repair Mechanisms (30 papers). Bridget T. Hill is often cited by papers focused on Cancer therapeutics and mechanisms (63 papers), Cancer Treatment and Pharmacology (32 papers) and DNA Repair Mechanisms (30 papers). Bridget T. Hill collaborates with scholars based in United Kingdom, France and United States. Bridget T. Hill's co-authors include Richard D. H. Whelan, Anna Kruczynski, Louise K. Hosking, L A Price, S. A. Whatley, Kenneth R. Harrap, Chantal Etiévant, Sharon A. Shellard, Leslie Wilson and Mary Ann Jordan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Bridget T. Hill

191 papers receiving 5.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bridget T. Hill United Kingdom	39	3.0k	2.2k	555	551	546	193	5.3k
M. Micksche Austria	47	2.7k 0.9×	1.9k 0.9×	407 0.7×	619 1.1×	296 0.5×	187	6.0k
William P. Tong United States	40	3.6k 1.2×	2.1k 1.0×	649 1.2×	641 1.2×	290 0.5×	110	6.6k
Gÿorgý Kéri Hungary	41	3.5k 1.2×	1.7k 0.8×	592 1.1×	535 1.0×	486 0.9×	162	6.1k
John F. Smyth United Kingdom	52	3.7k 1.2×	2.9k 1.3×	305 0.5×	921 1.7×	345 0.6×	202	8.2k
William N. Hait United States	38	2.8k 1.0×	2.0k 0.9×	241 0.4×	691 1.3×	536 1.0×	92	4.8k
Gerald B. Grindey United States	29	2.7k 0.9×	2.1k 0.9×	596 1.1×	714 1.3×	167 0.3×	84	5.4k
Graziella Pratesi Italy	42	3.7k 1.2×	3.9k 1.8×	758 1.4×	1.1k 1.9×	367 0.7×	147	6.7k
Thomas Meyer Switzerland	45	3.7k 1.2×	2.2k 1.0×	1.2k 2.2×	668 1.2×	371 0.7×	137	7.9k
Janet A. Houghton United States	46	4.3k 1.5×	3.0k 1.4×	239 0.4×	899 1.6×	241 0.4×	144	6.5k
Cristiano Ferlini Italy	41	3.0k 1.0×	1.7k 0.8×	512 0.9×	1.0k 1.8×	997 1.8×	136	5.3k

Countries citing papers authored by Bridget T. Hill

Since Specialization

Citations

This map shows the geographic impact of Bridget T. Hill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bridget T. Hill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bridget T. Hill more than expected).

Fields of papers citing papers by Bridget T. Hill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bridget T. Hill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bridget T. Hill. The network helps show where Bridget T. Hill may publish in the future.

Co-authorship network of co-authors of Bridget T. Hill

This figure shows the co-authorship network connecting the top 25 collaborators of Bridget T. Hill. A scholar is included among the top collaborators of Bridget T. Hill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bridget T. Hill. Bridget T. Hill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hill, Lauren, Bridget T. Hill, Malcolm Miller, & W L Michell. (2011). The effect of intra-abdominal hypertension on gastrointestinal function. 27(1). 12–19. 9 indexed citations

Debitus, Cécile, et al.. (2004). Heteronemin as a Protein Farnesyl Transferase Inhibitor. Pharmaceutical Biology. 42(6). 454–456. 23 indexed citations

Santelli‐Rouvier, Christiane, et al.. (2004). Synthesis of 9-acridinyl sulfur derivatives: sulfides, sulfoxides and sulfones. Comparison of their activity on tumour cells. European Journal of Medicinal Chemistry. 39(12). 1029–1038. 42 indexed citations

Perez, Michel, et al.. (2003). Synthesis and evaluation of a novel series of farnesyl protein transferase inhibitors as non-peptidic CAAX tetrapeptide analogues. Bioorganic & Medicinal Chemistry Letters. 13(8). 1455–1458. 6 indexed citations

Etiévant, Chantal, et al.. (2003). From pure FPP to mixed FPP and CAAX competitive inhibitors of farnesyl protein transferase. Bioorganic & Medicinal Chemistry Letters. 13(8). 1459–1462. 7 indexed citations

Hill, Bridget T., et al.. (2002). Inhibition of nucleotide excision repair and sensitisation of cells to DNA cross-linking anticancer drugs by F 11782, a novel fluorinated epipodophylloid. Biochemical Pharmacology. 63(2). 251–258. 32 indexed citations

Holwell, S E, Bridget T. Hill, & M C Bibby. (2001). Anti-vascular effects of vinflunine in the MAC 15A transplantable adenocarcinoma model. British Journal of Cancer. 84(2). 290–295. 44 indexed citations

Kruczynski, Anna & Bridget T. Hill. (2001). Vinflunine, the latest Vinca alkaloid in clinical development. Critical Reviews in Oncology/Hematology. 40(2). 159–173. 119 indexed citations

Etiévant, Chantal, Anna Kruczynski, Jean‐Marc Barret, et al.. (2000). F 11782, a dual inhibitor of topoisomerases I and II with an original mechanism of action in vitro, and markedly superior in vivo antitumour activity, relative to three other dual topoisomerase inhibitors, intoplicin, aclarubicin and TAS-103. Cancer Chemotherapy and Pharmacology. 46(2). 101–113. 24 indexed citations

10.

Kruczynski, Anna, Chantal Etiévant, Dominique Perrin, et al.. (2000). Preclinical antitumour activity of F 11782, a novel dual catalytic inhibitor of topoisomerases. British Journal of Cancer. 83(11). 1516–1524. 14 indexed citations

11.

Hille, B van, Dominique Perrin, & Bridget T. Hill. (1999). Differential in vitro interactions of a series of clinically useful topoisomerase-interacting compounds with the cleavage/religation activity of the human topoisomerase IIα and IIβ isoforms. Anti-Cancer Drugs. 10(6). 551–560. 5 indexed citations

12.

Perrin, Dominique, B van Hille, & Bridget T. Hill. (1998). Differential sensitivities of recombinant human topoisomerase IIα and β to various classes of topoisomerase II-interacting agents. Biochemical Pharmacology. 56(4). 503–507. 25 indexed citations

13.

Hill, Bridget T.. (1995). The links between mary wollstonecraft and catharine macaulay: new evidence. Women s History Review. 4(2). 177–192. 5 indexed citations

14.

Hill, Bridget T. & Louise K. Hosking. (1994). Differential effectiveness of a range of novel drug-resistance modulators, relative to verapamil, in influencing vinblastine or teniposide cytotoxicity in human lymphoblastoid CCRF-CEM sublines expressing classic or atypical multidrug resistance. Cancer Chemotherapy and Pharmacology. 33(4). 317–324. 10 indexed citations

15.

Hill, Bridget T., et al.. (1994). Differential formation and enhanced removal of specific cisplatin–DNA adducts in two cisplatin-selected resistant human testicular teratoma sublines. Anti-Cancer Drugs. 5(3). 321–328. 18 indexed citations

16.

Price, L A, H. J. Shaw, & Bridget T. Hill. (1993). Larynx preservation after initial non-cisplatin containing combination chemotherapy plus radiotherapy, as opposed to surgical intervention with or without radiotherapy in previously untreated advanced head and neck cancer: final analysis after 12 years follow-up. The Journal of Laryngology & Otology. 107(3). 211–216. 11 indexed citations

17.

Dempke, Wolfram C. M., Richard D. H. Whelan, & Bridget T. Hill. (1992). Expression off resistance to etoposide and vincristine in vitro and in vivo after X-irradiation of ovarian tumor cells. Anti-Cancer Drugs. 3(4). 395–400. 10 indexed citations

18.

Whelan, Richard D. H., Louise K. Hosking, Alan J. Townsend, Kenneth H. Cowan, & Bridget T. Hill. (1989). Differential Increases in Glutathione S-Transferase Activities in a Range of Multidrug-Resistant Human Tumor Cell Lines. PubMed. 1(6). 359–365. 43 indexed citations

19.

Dendy, P P & Bridget T. Hill. (1983). Human tumour drug sensitivity testing in vitro : techniques and clinical applications. Academic Press eBooks. 18 indexed citations

20.

Price, L A, Bridget T. Hill, & M.W. Ghilchik. (1981). Safer cancer chemotherapy. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact